反応 #45127

ord-30be1c6cc8ef46d7a2a6678d5a3c7f62

溶媒

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(1-prop-2-ynylpiperidin-4-yl)benzamide was prepared
  2. 2
    その他The crude product was purified by silica column chromatography
  3. 3
    洗浄eluting with a gradient of 0 to 5% 2.5M ammonia/methanol in DCM
  4. 4
    その他Pure fractions were evaporated to dryness
  5. 5
    その他the product crystallised from DCM/diethyl ether

実験手順

N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(1-prop-2-ynylpiperidin-4-yl)benzamide was prepared following the procedure as outlined for Example 99, starting from methyl 4-(1-prop-2-ynylpiperidin-4-yl)benzoate (0.257 g, 1.00 mmol) and 5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-amine (0.247 g, 1 mmol) in dry toluene (10 mL) with 2M trimethylaluminium (1.250 mL, 2.50 mmol). The crude product was purified by silica column chromatography, eluting with a gradient of 0 to 5% 2.5M ammonia/methanol in DCM. Pure fractions were evaporated to dryness and the product crystallised from DCM/diethyl ether to give the title compound (0.245 g, 51.8%) as a white solid.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07737149B2uspto-grants-2010_06